SDT-T002

N/A

Report date: 2023/06/14 13:40:17

Base Information

Drug NameSDT-T002
Drug Alias NameSDT-T002SDTT002
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCytocraft Beijing Bioengineering Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCytocraft Beijing Bioengineering Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A